# Totumo (Annona montana)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/totumo-annona-montana
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 1 / 10
**Category:** South American
**Also Known As:** Annona montana Macfad., Mountain soursop, Wild soursop, Totumo, Guanábana de monte

## Overview

Annona montana seeds contain at least 25 acetogenin-like compounds alongside linoleic acid (37%), α-tocopherol, β-sitosterol, and phenolic constituents that collectively drive documented [antioxidant](/ingredients/condition/antioxidant), cytotoxic, and insecticidal activities in laboratory assays. Seed ethanol extracts display a total phenolic content of 297.38 mg GAE/100 g and brine-shrimp cytotoxicity at LC50 3.22 mg/L, while stem-isolated amides including N-trans-caffeoyltyramine and N-trans-feruloyltyramine demonstrate antiplatelet aggregation activity in vitro; no human clinical evidence yet substantiates these effects.

## Health Benefits

- **[Antioxidant Activity](/ingredients/condition/antioxidant)**: Seed ethanol extracts exhibit a DPPH radical scavenging capacity of 385.46 mg TE/100 g and a FRAP value of 192.66 mg TE/100 g, attributed primarily to high total phenolic content (297.38 mg GAE/100 g) and the presence of α-tocopherol (19.97%) and β-tocopherol in leaf and methanol fractions.
- **Cytotoxic Potential Against Abnormal Cells**: Twenty-five acetogenin-like compounds identified by HPLC in seed extracts are structurally analogous to potent mitochondrial complex I inhibitors found in related Annona species, with brine-shrimp bioassays recording >80% mortality at 10 mg/L and LC50 values of 3.22–3.58 mg/L, suggesting biologically meaningful cytotoxicity warranting further oncological investigation.
- **Antiplatelet Aggregation**: Stem isolates of N-trans-caffeoyltyramine, N-trans-feruloyltyramine, and N-p-coumaroyltyramine have demonstrated antiplatelet activity in vitro, a property common to hydroxycinnamic acid amides that may reduce platelet aggregation through modulation of arachidonic acid pathways, though no clinical dose-response data exist.
- **Insecticidal and Antiparasitic Activity**: Ethanol seed extracts at 100 mg/L caused 67.5% mortality in Myzus persicae tabaci, while leaf and seed extracts showed equivalent potency against Aphis craccivora nymphs at comparable LC50 values, consistent with the lipophilic acetogenin and fatty acid profile disrupting insect [energy metabolism](/ingredients/condition/energy).
- **Adipogenesis Inhibition**: Methanol extracts containing β-caryophyllene, δ-cadinene, campesterol, and γ-sitosterol inhibited lipid droplet accumulation in 3T3-L1 preadipocytes at concentrations up to 40 μg/mL in vitro, suggesting a possible role in modulating adipocyte differentiation, though the precise intracellular signaling targets have not been characterized.
- **Phytosterol-Mediated Lipid Modulation**: β-Sitosterol (10.16% of leaf extract constituents) and β-sitosterol-β-D-glucoside isolated from the stem are structurally competitive inhibitors of intestinal cholesterol absorption, a mechanism well-established across the phytosterol class, lending biological plausibility to [cardiovascular](/ingredients/condition/heart-health)-adjacent benefits that remain unconfirmed in human studies for this species.

## Mechanism of Action

The primary cytotoxic mechanism inferred for Annona montana is attributable to its acetogenin-like compounds, which in structurally characterized relatives such as Annona muricata act as potent inhibitors of [mitochondrial](/ingredients/condition/energy) NADH-ubiquinone oxidoreductase (Complex I of the electron transport chain), disrupting ATP synthesis and triggering intrinsic apoptotic cascades; while direct Complex I binding assays have not been published for A. montana isolates, HPLC profiling of 25 acetogenin-like compounds in seed extracts and the observed brine-shrimp LC50 of 3.22 mg/L support this mechanistic inference. Phenolic constituents including N-trans-caffeoyltyramine and N-trans-feruloyltyramine from the stem appear to inhibit platelet aggregation via interference with thromboxane A2-dependent or collagen-induced pathways, consistent with reported activities of hydroxycinnamic acid amides in other botanical contexts. Antioxidant activity is mechanistically linked to the electron-donating capacity of α-tocopherol, β-tocopherol, and total phenolics, which quench [reactive oxygen species](/ingredients/condition/antioxidant) measured by DPPH and FRAP assays without requiring enzymatic mediation. Adipogenesis inhibition in 3T3-L1 cells at 40 μg/mL methanol extract may involve downregulation of PPARγ or C/EBPα transcription factors that drive lipid droplet formation, a mechanism associated with β-sitosterol and phytosterol-containing extracts in published adipocyte models, though gene-level confirmation for this species is absent.

## Clinical Summary

No human clinical trials have been conducted on Annona montana or any of its isolated constituents for any indication, including skin infections, cytotoxic applications, antiplatelet use, or [antioxidant](/ingredients/condition/antioxidant) supplementation. The totality of available research comprises laboratory-based phytochemical profiling, radical scavenging assays, invertebrate lethality tests, and single cell-line adipogenesis experiments, none of which generate effect-size estimates applicable to human populations. Outcomes such as brine-shrimp LC50 of 3.22 mg/L and 67.5% aphid mortality at 100 mg/L are biologically interesting but cannot be extrapolated to human therapeutic doses, bioavailability, or safety margins. Confidence in any clinical benefit remains very low, and Annona montana should be classified as a preclinical-stage botanical requiring systematic toxicology, pharmacokinetic evaluation, and phase I safety studies before human application can be responsibly assessed.

## Nutritional Profile

Annona montana seeds provide a lipid-rich nutritional matrix dominated by linoleic acid (omega-6, 37% of fatty acid content) and oleic acid (omega-9) as the principal fatty acids, with palmitic acid (C16:0) at 16.9% representing the primary saturated fraction; these constitute 97.2% of identified seed lipid constituents. Leaves contain α-tocopherol at 19.97% of identified extract constituents, β-tocopherol in methanol fractions, and phytol (4.43%), a tocopherol biosynthetic precursor with [antioxidant](/ingredients/condition/antioxidant) relevance. Phytosterol content includes β-sitosterol (10.16%), campesterol, and γ-sitosterol, which compete with dietary cholesterol for micellar incorporation and intestinal transporter binding via NPC1L1. Phenolic content of seed ethanol extracts reaches 297.38 mg gallic acid equivalents per 100 g extract, supporting moderate radical scavenging capacity, while minor constituents such as cyclohexanecarboxylic acid heptadecyl ester (6.26%), methyl linolenate (5.35%), β-caryophyllene, δ-cadinene, syringaldehyde, and (-)-syringaresinol complete the identified phytochemical inventory. Bioavailability of acetogenins and fat-soluble tocopherols would be expected to require lipid co-ingestion for adequate absorption, though no human pharmacokinetic data exist for this species.

## Dosage & Preparation

- **Ethanolic Seed Extract (Research Grade)**: Used at 12,500 mg/L for total phenolic content quantification in laboratory settings; no human-applicable dose established.
- **Hexanic Seed Extract (Research Grade)**: Prepared via hexane maceration to isolate fatty acids (linoleic acid 37%, oleic acid dominant); no supplemental dose range defined.
- **Methanol Leaf/Stem Extract (Research Grade)**: Applied at up to 40 μg/mL in cell culture for adipogenesis assays; translational human dosing unknown.
- **Traditional Aqueous Preparation**: Indigenous Colombian communities reportedly use leaf and fruit decoctions topically for skin conditions, though no standardized preparation volume, contact time, or concentration has been documented in peer-reviewed literature.
- **Standardization**: No commercial standardized extract exists; no minimum specification for acetogenin, tocopherol, or phenolic content has been established for any intended use.
- **Timing and Administration**: Not applicable — all current data derive from in vitro or invertebrate assays; human dosing guidance cannot be responsibly extrapolated from existing evidence.

## Safety & Drug Interactions

Annona montana extracts exhibit notable cytotoxicity in the brine-shrimp lethality assay at LC50 values of 3.22–3.58 mg/L, a threshold conventionally interpreted as indicating biologically significant toxicity potential; this warrants caution and precludes routine self-administration until mammalian acute and sub-chronic toxicity studies are completed. The stem-isolated antiplatelet amides (N-trans-caffeoyltyramine, N-trans-feruloyltyramine, N-p-coumaroyltyramine) present a theoretically elevated bleeding risk if co-administered with anticoagulants such as warfarin, direct oral anticoagulants (apixaban, rivaroxaban), or antiplatelet agents (aspirin, clopidogrel), though this interaction has not been empirically tested. No human side effect data, maximum tolerated dose, pregnancy or lactation safety information, hepatotoxicity assessments, or genotoxicity studies have been published; the structural relationship of its acetogenins to neurotoxic Annonaceae compounds implicated in atypical Parkinsonism (e.g., annonacin in A. muricata) raises a precautionary flag requiring direct investigation before any internal use recommendation. Annona montana should be considered contraindicated during pregnancy, lactation, and in patients with bleeding disorders or on anticoagulant therapy until human safety data are established.

## Scientific Research

The available body of evidence for Annona montana consists exclusively of in vitro bioassays and phytochemical characterization studies, with no published human clinical trials or controlled animal pharmacokinetic studies identified as of the research date. Key investigations include HPLC-based identification of 25 acetogenin-like compounds in Colombian seed extracts, spectrophotometric quantification of total phenolics and [antioxidant](/ingredients/condition/antioxidant) capacity (DPPH, FRAP), brine-shrimp lethality assays (LC50 3.22–3.58 mg/L), aphid insecticidal assays reporting 67.5% mortality at 100 mg/L, antiplatelet activity of stem amide isolates, and adipogenesis inhibition in 3T3-L1 preadipocytes up to 40 μg/mL. Statistical analyses across studies employed ANOVA with Tukey post-hoc correction at p<0.05, lending internal validity to comparative extract potency data, but the absence of in vivo mammalian toxicology, pharmacokinetic profiling, dose-escalation studies, or randomized trials severely constrains translational confidence. The evidence base is consistent with early-stage phytochemical discovery research and should not be interpreted as clinical efficacy or safety validation for human use.

## Historical & Cultural Context

Annona montana occupies a recognized place in Colombian and broader Amazonian indigenous ethnomedicine, where the fruit, leaves, and bark have been employed in traditional practices addressing skin infections, parasitic conditions, and [inflammatory](/ingredients/condition/inflammation) complaints, though these uses are documented primarily through ethnobotanical survey reports rather than controlled pharmacological investigation. The Annonaceae family has deep roots in pre-Columbian medicine across South and Central America, with related species such as Annona muricata (soursop) and Annona squamosa (sugar apple) carrying extensive recorded histories of use against fever, skin disease, and intestinal parasites in Amazonian, Caribbean, and Mesoamerican traditions. Preparation methods in traditional contexts reportedly include maceration of leaves in water or alcohol for topical application to infected or inflamed skin and decoctions of the stem bark for internal use, though no formal ethnopharmacological codification of A. montana-specific recipes with precise ingredient ratios or preparation durations has been published. The local Colombian common name 'totumo' is also applied to Crescentia cujete in some regions, a botanical homonym that creates nomenclatural ambiguity in non-peer-reviewed ethnobotanical accounts.

## Synergistic Combinations

No empirically validated synergistic ingredient combinations have been studied for Annona montana in published research; however, given the fat-soluble nature of its principal bioactives (acetogenins, tocopherols, phytosterols, fatty acids), co-administration with a dietary lipid source would theoretically enhance micellar solubilization and intestinal absorption, a principle well-established for other Annonaceae-derived lipophilic compounds. The antiplatelet activity of its stem amides could theoretically be additive with other platelet-modulating botanicals such as ginger (Zingiber officinale) or garlic (Allium sativum), though this combination has not been evaluated and carries an unquantified bleeding risk. Research into the Annonaceae family suggests that combining acetogenin-rich fractions with agents that modulate P-glycoprotein efflux (a mechanism explored in oncological contexts for related species) might augment cytotoxic selectivity, but no such study exists for A. montana specifically.

## Frequently Asked Questions

### What is totumo (Annona montana) used for traditionally?

In Colombian and broader Amazonian indigenous practice, Annona montana leaves, fruit, and stem bark have traditionally been applied to skin infections and inflammatory conditions, with decoctions and macerations used both topically and internally. However, these uses are documented primarily through ethnobotanical surveys rather than controlled clinical studies, so the efficacy and safety of traditional preparations remain scientifically unverified.

### Does Annona montana have proven anticancer effects?

No human clinical evidence supports anticancer claims for Annona montana. Laboratory assays show cytotoxicity attributed to 25 acetogenin-like compounds in seed extracts, with brine-shrimp LC50 values of 3.22–3.58 mg/L and >80% mortality at 10 mg/L, but these invertebrate toxicity models do not establish efficacy or safety in human cancer treatment. The compound class (acetogenins) includes potent mitochondrial Complex I inhibitors studied in related species, but direct mechanistic and clinical validation for A. montana is absent.

### Is totumo safe to take as a supplement?

No established safe supplemental dose exists for Annona montana, and the available evidence does not support recommending it as a supplement. Its extracts exhibit significant cytotoxicity in brine-shrimp assays, its acetogenins are structurally related to neurotoxic Annonaceae compounds implicated in atypical Parkinsonism, and no human toxicology, pharmacokinetic, or dose-escalation studies have been published. Individuals on anticoagulants or antiplatelet medications face a theoretical but unquantified bleeding risk from its stem-derived antiplatelet amides.

### What bioactive compounds are found in Annona montana seeds?

Annona montana seeds are particularly rich in linoleic acid (37% of fatty acids), oleic acid, and palmitic acid (16.9%), alongside 25 acetogenin-like compounds identified by HPLC with UV absorbance at 200–220 nm. Seed ethanol extracts contain high total phenolic content (297.38 mg GAE/100 g extract) with antioxidant capacity measured at 385.46 mg TE/100 g by DPPH and 192.66 mg TE/100 g by FRAP assay, making the seed the most phytochemically characterized plant part to date.

### How does Annona montana differ from soursop (Annona muricata)?

Annona montana (mountain soursop or totumo) and Annona muricata (soursop or guanábana) are closely related members of the Annonaceae family sharing a similar phytochemical scaffold, including acetogenins, phytosterols, and phenolic amides, but they are distinct species with different geographic distributions, morphological characteristics, and research profiles. A. muricata has been far more extensively studied with hundreds of published phytochemical and bioactivity reports, whereas A. montana remains at the early-stage phytochemical characterization phase with no human clinical trials, meaning the well-publicized properties of soursop cannot be directly attributed to totumo without independent experimental confirmation.

### What is the evidence quality for Annona montana's antioxidant effects?

In vitro studies demonstrate that Annona montana seed extracts show significant antioxidant capacity with DPPH radical scavenging of 385.46 mg TE/100 g and FRAP values of 192.66 mg TE/100 g, primarily due to high phenolic content (297.38 mg GAE/100 g). However, these results are from laboratory testing and have not been extensively validated in human clinical trials, limiting the ability to translate these findings to real-world supplementation outcomes. More rigorous human studies are needed to establish the clinical relevance of these antioxidant measurements.

### What forms of Annona montana extract have the highest antioxidant activity?

Ethanol seed extracts of Annona montana demonstrate superior antioxidant activity compared to other solvent preparations, with documented DPPH and FRAP values significantly higher than alternative extraction methods. Leaf and methanol fractions also show notable antioxidant potential due to their tocopherol content (α-tocopherol at 19.97% and β-tocopherol presence). The choice between seed versus leaf-based supplements may influence the bioactive compound profile and resulting antioxidant potency.

### Who should consider Annona montana supplementation based on its antioxidant profile?

Individuals seeking plant-based antioxidant support might consider Annona montana due to its high phenolic content and documented free-radical scavenging capacity in laboratory studies. However, without robust human clinical data, it is not specifically recommended for treating oxidative stress-related conditions or as a substitute for established antioxidant therapies. Consultation with a healthcare provider is advisable to determine whether Annona montana is appropriate for individual health goals.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*